EXACT SCIENCES CORP 4

Shacey Petrovic disposed of all remaining Exact Sciences Corp. common shares (direct and via a grantor retained annuity trust) for $105.00 per share in cash as part of Abbott’s merger closing.

On March 23, 2026, in connection with the closing of Abbott Laboratories’ acquisition of Exact Sciences Corporation, all of Shacey Petrovic’s remaining Exact Sciences common shares were automatically converted into cash at $105.00 per share pursuant to the merger agreement. The Form 4 reflects a disposition of 16,406 shares of common stock held directly, reducing that direct position to 5,398 shares, and the disposition of an additional 5,398 shares held directly and 7,095 shares held indirectly via a grantor retained annuity trust, bringing those positions to zero as the merger consideration was paid. These are merger-driven, non‑discretionary sales where all outstanding and restricted shares were cancelled and cashed out at the fixed merger price, leaving Petrovic with no remaining equity in Exact Sciences, which became a wholly owned subsidiary of Abbott.

Filing Facts

CIK

1124140

Ticker

EXAS

Form

4

Source Type

sec

Accession

0001193125-26-118748

Alert Tier

6